• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钆塞酸二钠增强MRI上非癌性肝实质的异质性:慢性肝病中肝细胞癌发生的一种影像学生物标志物

Heterogeneity of non-cancerous liver parenchyma on gadoxetic acid-enhanced MRI: an imaging biomarker for hepatocellular carcinoma development in chronic liver disease.

作者信息

Asayama Y, Nishie A, Ishigami K, Ushijima Y, Takayama Y, Okamoto D, Fujita N, Morita K, Obara M, Honda H

机构信息

Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.

Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.

出版信息

Clin Radiol. 2016 May;71(5):432-7. doi: 10.1016/j.crad.2016.01.023. Epub 2016 Mar 2.

DOI:10.1016/j.crad.2016.01.023
PMID:26944697
Abstract

AIM

To clarify whether the heterogeneity of non-cancerous liver parenchyma (NLP) in the hepatobiliary phase on gadoxetic acid enhanced magnetic resonance imaging (MRI) is correlated with hepatocellular carcinoma (HCC) development.

MATERIALS AND METHODS

Institutional review board approval was obtained, and the requirements for informed consent were waived for this retrospective study. The imaging characteristics of 84 patients with chronic liver disease who underwent gadoxetic acid-enhanced 3T MRI between January 2013 and October 2014 were examined retrospectively. For the evaluation of the heterogeneity of the intensity in the hepatobiliary phase, the largest possible region of interest was placed on the NLP, and the skewness and kurtosis were calculated using ImageJ software. Skewness is the degree of asymmetry of a histogram, and kurtosis is a measure of the peak. Based on the median values of kurtosis and skewness, the patients were classified into four categories and the categories were compared between the 49 patients with HCC (HCC group) and the 35 patients without HCC (non-HCC group).

RESULTS

Kurtosis was significantly higher in the HCC group compared to the non-HCC group (1.19±1.15 versus 0.43±0.83; p=0.0006). Skewness was significantly lower in the HCC group than in the non-HCC group (1.19±1.15 versus 0.43±0.83; p=0.0152). In a multivariate logistic analysis, the category showing lower-than-the-median (-0.1185) skewness and higher-than-the-median (0.547) kurtosis was significantly and independently associated with HCC development (p=0.0031).

CONCLUSION

The heterogeneity of NLP in the hepatobiliary phase on gadoxetic acid enhanced MRI may reflect the development of HCC.

摘要

目的

明确钆塞酸增强磁共振成像(MRI)肝胆期非癌性肝实质(NLP)的异质性是否与肝细胞癌(HCC)的发生相关。

材料与方法

本回顾性研究获得了机构审查委员会的批准,并豁免了知情同意的要求。回顾性分析了2013年1月至2014年10月期间接受钆塞酸增强3T MRI检查的84例慢性肝病患者的影像特征。为评估肝胆期信号强度的异质性,在NLP上放置尽可能大的感兴趣区,并使用ImageJ软件计算偏度和峰度。偏度是直方图不对称程度的度量,峰度是峰值的度量。根据峰度和偏度的中位数,将患者分为四类,并比较49例HCC患者(HCC组)和35例无HCC患者(非HCC组)之间的类别。

结果

HCC组的峰度显著高于非HCC组(1.19±1.15对0.43±0.83;p = 0.0006)。HCC组的偏度显著低于非HCC组(1.19±1.15对0.43±0.83;p = 0.0152)。在多因素逻辑分析中,显示低于中位数(-0.1185)偏度和高于中位数(0.547)峰度的类别与HCC发生显著且独立相关(p = 0.0031)。

结论

钆塞酸增强MRI肝胆期NLP的异质性可能反映HCC的发生。

相似文献

1
Heterogeneity of non-cancerous liver parenchyma on gadoxetic acid-enhanced MRI: an imaging biomarker for hepatocellular carcinoma development in chronic liver disease.钆塞酸二钠增强MRI上非癌性肝实质的异质性:慢性肝病中肝细胞癌发生的一种影像学生物标志物
Clin Radiol. 2016 May;71(5):432-7. doi: 10.1016/j.crad.2016.01.023. Epub 2016 Mar 2.
2
Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.钆塞酸增强肝脏磁共振成像在检测 HCC 和根据米兰标准和 UNOS 指南分配肝移植受者中的诊断性能:与组织病理学发现的相关性。
Radiology. 2015 Jan;274(1):149-60. doi: 10.1148/radiol.14140141. Epub 2014 Sep 5.
3
Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease.钆塞酸二钠增强磁共振成像肝胆期上小于1厘米的低信号结节的影像学特征,这些结节在慢性肝病患者中进展为高血供肝细胞癌。
Acta Radiol. 2015 May;56(5):526-35. doi: 10.1177/0284185114534652. Epub 2014 May 16.
4
Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging.慢性肝病患者直径 1 厘米或更小的富血管性肝细胞癌:包括弥散加权成像在内的钆塞酸增强 MRI 的特征。
AJR Am J Roentgenol. 2011 Jun;196(6):W758-65. doi: 10.2214/AJR.10.4394.
5
Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma.钆塞酸增强肝胆期磁共振成像在肝细胞癌诊断中的应用价值。
Radiology. 2010 May;255(2):459-66. doi: 10.1148/radiol.10091388.
6
Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.钆塞酸增强肝胆期 MRI 和高 b 值扩散加权成像在慢性肝病患者中鉴别高分化肝细胞癌与良性结节
AJR Am J Roentgenol. 2011 Nov;197(5):W868-75. doi: 10.2214/AJR.10.6237.
7
Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.钆塞酸增强磁共振成像在鉴别 < 或 = 2cm 直径的小肝癌和动脉期增强假性病灶中的应用:特别强调肝胆期成像。
Invest Radiol. 2010 Feb;45(2):96-103. doi: 10.1097/RLI.0b013e3181c5faf7.
8
Hypovascular hypointense nodules on hepatobiliary phase gadoxetic acid-enhanced MR images in patients with cirrhosis: potential of DW imaging in predicting progression to hypervascular HCC.肝硬化患者肝胆期钆塞酸增强 MRI 上低血供低信号结节:弥散加权成像预测向富血供 HCC 进展的潜力。
Radiology. 2012 Oct;265(1):104-14. doi: 10.1148/radiol.12112649. Epub 2012 Aug 13.
9
Detection of small hepatocellular carcinoma using gadoxetic acid-enhanced MRI: Is the addition of diffusion-weighted MRI at 3.0T beneficial?使用钆塞酸增强 MRI 检测小肝细胞癌:3.0T 时添加弥散加权 MRI 是否有益?
J Dig Dis. 2014 Mar;15(3):137-45. doi: 10.1111/1751-2980.12119.
10
Small (≤1-cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imaging.小肝癌(≤1cm):钆塞酸增强磁共振成像的诊断性能和影像学特征。
Radiology. 2014 Jun;271(3):748-60. doi: 10.1148/radiol.14131996. Epub 2014 Feb 1.

引用本文的文献

1
Multi-View Radiomics Feature Fusion Reveals Distinct Immuno-Oncological Characteristics and Clinical Prognoses in Hepatocellular Carcinoma.多视图放射组学特征融合揭示肝细胞癌独特的免疫肿瘤学特征和临床预后
Cancers (Basel). 2023 Apr 17;15(8):2338. doi: 10.3390/cancers15082338.
2
Systematic review: radiomics for the diagnosis and prognosis of hepatocellular carcinoma.系统评价:放射组学在肝细胞癌诊断和预后中的应用。
Aliment Pharmacol Ther. 2021 Oct;54(7):890-901. doi: 10.1111/apt.16563. Epub 2021 Aug 12.
3
Increased and More Heterogeneous Gadoxetic Acid Uptake of the Liver Parenchyma after Hepatitis C Virus Eradication by Direct Antiviral Agent.
直接抗病毒药物清除丙型肝炎病毒后肝脏实质的钆塞酸摄取增加且更多样化。
Magn Reson Med Sci. 2020 Dec 1;19(4):389-393. doi: 10.2463/mrms.tn.2019-0183. Epub 2020 Feb 13.
4
The Efficacy of MRI in the diagnostic workup of cystic fibrosis-associated liver disease: A clinical observational cohort study.MRI 在囊性纤维化相关性肝病诊断中的作用:一项临床观察队列研究。
Eur Radiol. 2019 Feb;29(2):1048-1058. doi: 10.1007/s00330-018-5650-5. Epub 2018 Jul 27.